My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
Discover the secret world of unlisted shares — analyse India's top pre-IPO companies and invest before they hit the markets
Nifty 50
25879.15
+3.35 (+0.01%)
Sensex
84478.67
+12.16 (+0.01%)
BSE: 500076 | NSE: BURRWELCOM | Series: NA | ISIN: INE157A01010 | SECTOR: PharmaceuticalsPharmaceuticals
BSE Live
Prev. Close
909.55
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
NSE Live
226.50
01.01.1970
22.07.2021
Gland Pharma’s new product play for FY22 holds a lot of promise
15.11.2017
Hold Indoco Remedies; target of Rs 250: ICICI Direct
05.10.2017
Buy Natco Pharma; target of Rs 1065: ICICI Direct
18.07.2017
Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey
28.02.2017
Sanofi India Q4 net declines 58% to Rs 50.5 cr
27.02.2017
Merck Dec-qtr net up 25% at Rs 18 cr
14.02.2017
Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3
Sun Pharma Q3 profit dragged by slowdown in US & India sales
13.02.2017
Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%
09.02.2017
Aurobindo Q3 profit seen up 14%, revenue may grow 10% on US biz
Lupin Q3 profit seen up 15% to Rs 609cr, US biz may lift revenue
15.02.2017
Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages
06.02.2017
Good Q3 but Dr Reddy's still far from sustainable growth: Expert
10.11.2016
Sun Pharma Q2 show healthy but margins unsustainable: Nangra
09.11.2016
Low earnings for Lupin to continue for next 2 qtrs: IIFL